Your browser is no longer supported. Please, upgrade your browser.
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 79 #1
TickerIFON [NASD]
CompanyInfosonics Corp.
CountryUSA
IndustryCommunication Equipment
Market Cap24.40MEPS (ttm)-0.02
P/E-EPS this Y77.80%
Forward P/E-EPS next Y-
PEG-EPS past 5Y37.50%
P/S0.58EPS next 5Y-
P/B1.53EPS Q/Q-
Dividend-Sales Q/Q-18.20%
Insider Own29.33%Inst Own5.80%
Insider Trans0.00%Inst Trans4.65%
Short Float7.08%EarningsMar 04
Analyst Recom-Target Price7.00
Avg Volume102.22K52W Range1.06 - 4.69
Mar-04-15 10:58AMInfoSonics (IFON) Stock Is Up Today After Positive Quarter at TheStreet
Mar-04-15 09:05AM9:05 am InfoSonics surging premarket: Q4 EPS $0.05 vs. $0.01 lsat year; rev +50% to $17.9 mln (no estimates) Briefing.com
Mar-04-15 09:00AMInfoSonics Reports Fourth Quarter and Full Year 2014 Results PR Newswire
Mar-04-15 06:12AMINFOSONICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
Feb-17-15 09:00AMInfoSonics Goes Big with the Introduction of a 6-Inch Phablet: the verykool® s6001 Cyprus PR Newswire
Feb-02-15 09:00AMInfoSonics® Releases Its First 'Selfie Smartphone' Featuring Front-Facing 5MP Auto-Focus Camera with LED Flash: the verykool® S5015 'Spark II' PR Newswire
Jan-27-15 01:20PM4 Stocks Under $10 Triggering Breakout Trades: Mid-Con Energy and More at TheStreet
Jan-23-15 12:52PM3 Tech Stocks Under $10 Ready for Breakouts: Ifosonics and More at TheStreet
Dec-17-14 10:50AMInfosonics (IFON) Downgraded From Hold to Sell at TheStreet
Dec-08-14 06:17AMINFOSONICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obliga EDGAR Online
InfoSonics Corporation designs, develops, manufactures, and sells wireless telecommunication products and accessories to wireless carriers, distributors, retailers, dealer agents, resellers, and original equipment manufacturers. Its products include wireless handsets; entry-level, mid-tier, and high-end feature phones; Android-based smartphones; and tablets and accessories. The company markets its products under verykool brand name in Latin America, as well as on a private label basis in the Asia Pacific, Europe, and Africa. InfoSonics Corporation was founded in 1994 and is headquartered in San Diego, California.
TickerNVGN [NASD]
CompanyNovogen Limited
CountryAustralia
IndustryDrug Manufacturers - Major
Market Cap25.25MEPS (ttm)-0.92
P/E-EPS this Y-210.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y23.80%
P/S16.08EPS next 5Y-
P/B13.97EPS Q/Q-440.00%
Dividend-Sales Q/Q5341.20%
Insider Own4.79%Inst Own1.00%
Insider Trans0.00%Inst Trans131.34%
Short Float3.77%Earnings-
Analyst Recom-Target Price-
Avg Volume749.89K52W Range1.51 - 5.97
Mar-04-15 06:00AMUS Studies Confirm Ability of TRXE-009 to Kill Brain Cancer Stem Cells PR Newswire
Mar-02-15 10:02PMNovogen to Present at AusBiotech "Broker Meets Biotech" Event PR Newswire
Feb-22-15 09:41PMNovogen to Present at SACHS Cancer Bio Partnering & Investment Forum PR Newswire
Feb-19-15 03:47PMNovogen Investor Briefing Well Received PR Newswire
Feb-11-15 10:00AMNovogen Lodges Key Super-benzopyran Patent PR Newswire
Feb-03-15 10:00AMNovogen to present at BIO & CEO Investor Conference 9th & 10th February, 2015 PR Newswire
Jan-15-15 10:45AMNovogen Soars 50% Following Brain Stem Cell News Benzinga
Jan-15-15 10:00AMNovogen Announces Important Discovery in Regenerative Medicine Program PR Newswire
Jan-07-15 10:00AMNovogen to Conduct Shareholder/Investor Briefing in New York PR Newswire
Dec-19-14 10:00AMNovogen Raises An Additional A$1.75m in Private Placement to US Institutions for Aggregate Private Placement of A$5.85m PR Newswire
Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). Its SBPs technology platform offers drug candidates, which include Cantrixil, an intra-peritoneal product intended for the treatment of abdominal cancers, such as ovarian and pancreatic cancer; Trilexium that is intended for the treatment of neural cancers, including glioblastoma and neuroblastoma; and Trx-7 for the treatment of prostate cancer. The company's ATMs technology platform targets the cytoskeleton of the cancer cell. Novogen Limited was founded in 1994 and is based in Hornsby, Australia.
TickerCAPN [NASD]
CompanyCapnia, Inc.
CountryUSA
IndustryDiagnostic Substances
Market Cap50.70MEPS (ttm)-1.02
P/E-EPS this Y43.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-50.00%
Dividend-Sales Q/Q-
Insider Own3.80%Inst Own52.20%
Insider Trans0.00%Inst Trans-
Short Float0.52%Earnings-
Analyst Recom-Target Price-
Avg Volume431.57K52W Range1.02 - 8.19
Mar-02-15 11:36AMThese are the most profitable Nasdaq biotech companies at MarketWatch
Feb-26-15 10:00AMCapnia, Inc. (Nasdaq: CAPN) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
Feb-25-15 04:25PM10 cheapest stocks in the Nasdaqs hottest sector at MarketWatch
Feb-23-15 05:48PM10 stocks that are pushing the Nasdaq to 5,000 at MarketWatch
Feb-17-15 07:00AMCapnia Announces First U.S. Commercial Sales of CoSense(R) GlobeNewswire
Jan-28-15 07:00AMCapnia Announces Publication of CoSense® Scientific Data in the Journal Blood Cells, Molecules and Diseases PR Newswire
Jan-08-15 07:00AMCapnia Applies for Orphan Drug Designation in the U.S. for the Treatment of Trigeminal Neuralgia PR Newswire
Jan-06-15 07:00AMCapnia and Clinvest® Partner to Develop Cluster Headache Therapeutic PR Newswire
Jan-05-15 07:00AMCapnia to Present at OneMedForum 2015 PR Newswire
Dec-18-14 04:26PMCAPNIA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Offi EDGAR Online
Capnia, Inc. develops and commercializes therapeutics and diagnostics products. The company offers CoSense for the diagnosis of excessive hemolysis in neonates, a condition that causes long-term developmental disability due to degradation of red blood cells. It also develops Serenz, a therapeutic product candidate that has completed Phase II clinical trials for the treatment of symptoms related to allergic rhinitis. The company was founded in 1999 and is based in Redwood City, California.
TickerPHMD [NASD]
CompanyPhotoMedex, Inc.
CountryUSA
IndustryMedical Appliances & Equipment
Market Cap34.88MEPS (ttm)-1.05
P/E-EPS this Y-17.60%
Forward P/E-EPS next Y73.70%
PEG-EPS past 5Y16.20%
P/S0.16EPS next 5Y15.00%
P/B0.24EPS Q/Q-
Dividend-Sales Q/Q17.00%
Insider Own25.00%Inst Own41.40%
Insider Trans-1.14%Inst Trans-5.63%
Short Float44.09%EarningsMar 12/b
Analyst Recom2.70Target Price18.00
Avg Volume657.43K52W Range1.01 - 16.82
Mar-03-15 04:29PMPHOTOMEDEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
Feb-05-15 03:39PMPHOTOMEDEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositi EDGAR Online
Feb-04-15 09:02AMDeutsche Bank Quants Identify Best Stocks To Short Benzinga
Feb-02-15 03:01PMPHOTOMEDEX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Feb-02-15 02:55PMPhotoMedex Sells LCA-Vision Subsidiary to Vision Acquisition, LLC for $40 Million Business Wire
Jan-30-15 04:56PMPHOTOMEDEX INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
Jan-30-15 01:53PMPHOTOMEDEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
Dec-16-14 08:02AMPHOTOMEDEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities EDGAR Online
Nov-18-14 01:04PMPHOTOMEDEX INC Financials EDGAR Online Financials
Nov-10-14 01:04PMPHOTOMEDEX INC Files SEC form 10-Q, Quarterly Report EDGAR Online
PhotoMedex, Inc., a skin health company, provides integrated disease management and aesthetic solutions to dermatologists, professional aestheticians, and consumers in North America, the Asia Pacific, Europe, and South America. The company operates in three segments: Consumer, Physician Recurring, and Professional. It offers products and services that address skin diseases and conditions, including psoriasis, vitiligo, acne, and photo damage. The company also provides a range of home-use devices under the no!no! brand name for various indications, such as hair removal, acne treatment, skin rejuvenation, and lower back pain; and a professional product line for acne clearance, skin tightening, psoriasis care, and hair removal to physician clinics and spas. In addition, it offers XTRAC excimer lasers used for the treatment of psoriasis and other skin diseases; NEOVA skin care products for preventing premature skin aging due to ultraviolet-induced DNA damage; and Omnilux light therapy systems to treat wrinkles, acne, minor muscle pain, and pigmented lesions. Further, the company provides Lumire light therapy equipment for use in non-medical applications, as well as a line of topical lotions to improve the appearance of fine lines, wrinkles, skin tone, and blemishes. Additionally, it develops, manufactures, and sells surgical products, including proprietary free-beam and Contact Laser systems for surgery; sells surgical disposables and accessories to hospitals and surgery centers; and repairs, maintains, and replaces parts on its products. PhotoMedex, Inc. was founded in 1980 and is headquartered in Horsham, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCGRATH DENNIS MPresident & CFODec 16Sale1.1624,59028,633256,136Dec 16 05:07 PM
MCGRATH DENNIS MPresident & CFODec 15Sale1.1230,41033,980280,726Dec 16 05:07 PM
Rafaeli DolevCEOApr 01Sale15.3717,829274,082523,874Apr 03 03:26 PM
Rafaeli DolevCEOMar 11Sale15.0119,690295,448541,703Mar 11 04:53 PM
Rafaeli DolevCEOMar 10Sale15.063,60054,214561,393Mar 11 04:53 PM
TickerSPPR [NASD]
CompanySupertel Hospitality, Inc.
CountryUSA
IndustryREIT - Hotel/Motel
Market Cap7.03MEPS (ttm)-5.31
P/E-EPS this Y81.90%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-54.90%
P/S0.13EPS next 5Y8.00%
P/B0.32EPS Q/Q-
Dividend-Sales Q/Q8.30%
Insider Own0.70%Inst Own3.90%
Insider Trans0.00%Inst Trans17.94%
Short Float0.92%EarningsFeb 12
Analyst Recom3.00Target Price2.00
Avg Volume7.71K52W Range1.17 - 3.17
Mar-03-15 05:02PM5:02 pm Supertel Hospitality announces William Blackham as new CEO Briefing.com
Mar-03-15 05:01PMHospitality Veteran William Blackham Joins Supertel Hospitality as CEO Marketwired
Feb-19-15 06:01AMSUPERTEL HOSPITALITY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online
Feb-03-15 05:53PMSupertel Hospitality Announces Sale of Hotel Properties for $3.65 Million Marketwired
Jan-16-15 04:16PMSUPERTEL HOSPITALITY INC Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
Dec-30-14 04:15PMSUPERTEL HOSPITALITY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online
Dec-29-14 04:13PMSUPERTEL HOSPITALITY INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi EDGAR Online
Dec-19-14 04:16PMSUPERTEL HOSPITALITY INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi EDGAR Online
Nov-26-14 01:04PMSUPERTEL HOSPITALITY INC Financials EDGAR Online Financials
Nov-21-14 04:03PMSUPERTEL HOSPITALITY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online
Supertel Hospitality, Inc. is an independent equity real estate investment trust. The firm invests in the real estate markets of the United States. It primarily invests in limited-service hotels. The firm was formerly known as Humphrey Hospitality Trust, Inc. Supertel Hospitality, Inc. was launched on August 23, 1994 and is based in Norfolk, Nebraska.
TickerCNDO [NASD]
CompanyCoronado Biosciences, Inc.
CountryUSA
IndustryBiotechnology
Market Cap123.65MEPS (ttm)-0.74
P/E-EPS this Y4.70%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-42.20%
P/S-EPS next 5Y26.20%
P/B1.45EPS Q/Q45.80%
Dividend-Sales Q/Q-
Insider Own26.70%Inst Own17.40%
Insider Trans11.09%Inst Trans-1.53%
Short Float12.39%EarningsMar 12/b
Analyst Recom4.00Target Price1.00
Avg Volume248.00K52W Range1.45 - 2.88
Mar-04-15 08:30AMTG Therapeutics Enters Into a Global Collaboration With Checkpoint Therapeutics to Develop and Commercialize Novel Immuno-Oncology Targeted Antibodies GlobeNewswire
Mar-04-15 08:30AMCoronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology Antibodies GlobeNewswire
Mar-03-15 08:35AM8:35 am Coronado Biosciences has closed a private placement of a promissory note for $10 mln Briefing.com
Mar-03-15 08:30AMCoronado Biosciences Closes $10 Million Private Placement Financing GlobeNewswire
Feb-26-15 08:51AMCoronado Biosciences (CNDO) Jumps: Stock Rises 10.7% - Tale of the Tape Zacks
Feb-19-15 12:20PMCoronado Biosciences In-Licenses Revogenex's Pain Drug - Analyst Blog Zacks
Feb-18-15 08:30AMCoronado Biosciences In-Licenses IV Tramadol, a Phase III Ready Asset, From Revogenex Ireland Ltd. GlobeNewswire
Jan-19-15 09:39AMCoronado Biosciences (CNDO) Looks Good: Stock Up 7.4% - Tale of the Tape Zacks
Jan-06-15 08:15AMCoronado Biosciences Reports on Separation of CB Pharma Acquisition Corp. Securities GlobeNewswire
Dec-29-14 08:15AMCoronado Biosciences Announces Exercise of Portion of Over-Allotment Option in Conjunction With CB Pharma Acquisition Corp. IPO GlobeNewswire
Coronado Biosciences, Inc., a development stage biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. The company's principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201, a biologic comprising the microscopic eggs of the porcine whipworm for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis, multiple sclerosis, autism, psoriasis, and type 1 diabetes; and CNDO-109, a biologic that activates the immune system's natural killer cells to seek and destroy cancer cells for the treatment of acute myeloid leukemia. Coronado Biosciences, Inc. has strategic alliances and commercial agreements with Ovamed GmbH, Dr. Falk Pharma GmbH, Freie Universitt Berlin, UCL Business PCL, and Progenitor Cell Therapy. The company was founded in 2006 and is based in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROSENWALD LINDSAY A MDPresident and CEODec 01Buy1.459741,4124,791,321Dec 03 04:51 PM
Lu LucyChief Financial OfficerDec 01Buy1.455,0007,25035,631Dec 03 04:50 PM
ROSENWALD LINDSAY A MDPresident and CEONov 06Buy1.61150,000241,5004,790,347Nov 10 04:19 PM
Hoenlein MalcolmDirectorNov 06Buy1.6125,00040,25055,000Nov 10 04:23 PM
WEISS MICHAEL SExec. VC - Strategic Dev.Nov 06Buy1.611,000,0001,610,0006,938,038Nov 10 04:25 PM
TickerCECO [NASD]
CompanyCareer Education Corp.
CountryUSA
IndustryEducation & Training Services
Market Cap345.15MEPS (ttm)-3.50
P/E-EPS this Y-34.80%
Forward P/E-EPS next Y48.30%
PEG-EPS past 5Y-37.40%
P/S0.36EPS next 5Y13.00%
P/B1.13EPS Q/Q-30.80%
Dividend-Sales Q/Q-6.80%
Insider Own0.10%Inst Own71.40%
Insider Trans0.00%Inst Trans5.42%
Short Float4.80%EarningsMar 03/a
Analyst Recom2.60Target Price6.00
Avg Volume550.93K52W Range4.32 - 7.85
Mar-03-15 06:59PMCareer Education jumps on narrower-than-expected loss AP
Mar-03-15 04:58PMCareer Education (CECO) Stock Rises in After-Hours Trading on a Narrower Than Expected Loss at TheStreet
Mar-03-15 04:33PMCareer Education reports 4Q loss AP
Mar-03-15 04:08PMCAREER EDUCATION CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
Mar-03-15 04:05PMCareer Education Corporation Reports Fourth Quarter and Fiscal Year 2014 Results Business Wire
Mar-03-15 07:07AMQ4 2014 Career Education Corp Earnings Release - After Market Close CCBN
Mar-02-15 01:43PMSell Career Education Stock Ahead of Earnings on Low Student Enrollment at TheStreet
Feb-26-15 04:17PMCAREER EDUCATION CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events EDGAR Online
Feb-18-15 09:00AMInstructional Technology Council Recognizes Colorado Technical University for Online Degree Programs Business Wire
Feb-12-15 04:10PMCareer Education Corporation Announces Fourth Quarter and Fiscal Year 2014 Earnings Conference Call Time Business Wire
Career Education Corporation operates schools and universities that provide education to student population in various career-oriented disciplines through online, on-ground, and hybrid learning program offerings in the United States. The company operates in six segments: Colorado Technical University, American InterContinental University, Health Education, Culinary Arts, Design & Technology, and Transitional Schools. Its institutions include American Intercontinental University; Brooks Institute; Colorado Technical University; Harrington College of Design; International Academy of Design & Technology; Le Cordon Bleu North America; and Sanford-Brown Institutes and Colleges. The company offers doctoral, master's, bachelor's, and associate degrees, as well as diploma and certificate programs. It also provides academic programs in disciplines, including business studies, information systems and technologies, criminal justice, computer science and engineering, health sciences, and design technologies in an online, classroom, or laboratory setting; culinary arts programs in disciplines of culinary arts, patisserie, and baking in the commercial kitchens of Le Cordon Bleu; and culinary arts, and hotel and restaurant management online. In addition, the company offers academic programs primarily in disciplines comprising visual communications, fashion design, photography, interior design, graphic design, and video production in a classroom, laboratory, or online setting, as well as continuing education and short-term vocational programs in the area of energy conservation. As of December 31, 2013, it had a total student enrollment of approximately 53,700 students. Career Education Corporation was founded in 1994 and is based in Schaumburg, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCCRAY RONALD DDirectorAug 14Buy5.121,0005,12016,619Aug 15 05:35 PM
SIMPSON REID ESVP, CFOJun 06Buy4.7110,00047,10064,612Jun 10 03:39 PM
Jones Diane AuerSVP, Chief Ext Affairs OfficerMar 14Sale6.712,48116,64820,082Mar 17 03:59 PM
Clemens Lysa ASVPMar 06Buy7.192,70019,41324,196Mar 10 05:31 PM
TickerEFUT [NASD]
Companye-Future Information Technology Inc.
CountryChina
IndustryApplication Software
Market Cap16.44MEPS (ttm)-0.23
P/E-EPS this Y-47.40%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-47.60%
P/S0.58EPS next 5Y-
P/B1.00EPS Q/Q-16.70%
Dividend-Sales Q/Q-16.90%
Insider Own-Inst Own0.50%
Insider Trans-Inst Trans33.56%
Short Float0.09%EarningsMar 03/a
Analyst Recom-Target Price-
Avg Volume7.85K52W Range3.12 - 7.09
Mar-03-15 05:00PMeFuture Announces Unaudited Fourth Quarter and Full Year 2014 Financial Results GlobeNewswire
Mar-03-15 07:07AMQ4 2014 eFuture Information Technology Inc Earnings Release - After Market Close CCBN
Feb-12-15 08:00AMeFuture Schedules 2014 Fourth Quarter and Fiscal Year 2014 Earnings Release on March 3, 2015 GlobeNewswire
Dec-30-14 08:00AMeFuture Announces Voting Results of Its 2014 Annual General Meeting GlobeNewswire
May-09-14 01:04PMEFUTURE INFORMATION TECHNOLOGY INC. Financials EDGAR Online Financials
Mar-18-14 11:54AMeFuture Information Technology's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
eFuture Information Technology Inc. provides software and services to retail and consumer goods industries in the People's Republic of China. The company develops and sells enterprise resource planning software, and provides solutions for distribution, retail, and logistics businesses. It offers software solutions, which include foundation solutions for retail management, point of sale, distribution management, logistics management, warehouse management, vendor payment and control, and loyalty card management; collaborative solutions for visual SCM and visual process management systems; and intelligent solutions for business intelligence, brand analysis, supplier relationship management, and customer relationship management systems. The company also provides support services on existing software installations; delivery services; consulting services, including systems planning and design, customer-specific configuration of application modules, and on-site implementation or conversion from existing systems; post-implementation consulting services, such as utilization reviews and business process optimization; and outsourcing services comprising design, development, implementation, operation, and improvement of information technology and business functions. In addition, it offers myStore, a mobile shopping social platform; and omni-channel cloud services, including myStore-driven omni-channel solutions, digital labor cloud services, and digital social media marketing services. The company serves manufacturers, distributors, wholesalers, logistics companies, and retailers in front-end supply chain market. It has partnership with IBM and Oracle to co-develop software and to implement partners' solutions; and strategic partnership with Retail Pro International, LLC to provide technical support and services. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
TickerPTN [AMEX]
CompanyPalatin Technologies Inc.
CountryUSA
IndustryDiagnostic Substances
Market Cap45.73MEPS (ttm)-0.02
P/E-EPS this Y38.10%
Forward P/E-EPS next Y-175.00%
PEG-EPS past 5Y25.30%
P/S3.52EPS next 5Y-
P/B3.67EPS Q/Q200.00%
Dividend-Sales Q/Q-
Insider Own1.78%Inst Own27.50%
Insider Trans0.00%Inst Trans15.31%
Short Float1.92%EarningsFeb 13/b
Analyst Recom2.00Target Price3.83
Avg Volume118.10K52W Range0.59 - 1.50
Feb-20-15 07:30AMPalatin Launches reconnectstudy.com in Support of Bremelanotide Phase 3 Program for Female Sexual Dysfunction PR Newswire
Feb-19-15 01:04PMPALATIN TECHNOLOGIES INC Financials EDGAR Online Financials
Feb-17-15 08:34AMMacrocure (MCUR) in Focus: Stock Falls 5.5% - Tale of the Tape Zacks
Feb-13-15 09:27AMPALATIN TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
Feb-13-15 07:30AMPalatin Technologies, Inc. Reports Second Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on February 13, 2015 PR Newswire
Feb-13-15 07:07AMQ2 2015 Palatin Technologies Inc Earnings Release - Before Market Open CCBN
Feb-12-15 04:11PMPALATIN TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Feb-09-15 04:39PMPalatin Technologies, Inc. To Report Second Quarter Fiscal Year 2015 Results Teleconference and Webcast to be held on February 13, 2015 PR Newswire
Feb-06-15 04:01PMPalatin Technologies To Present At The BIO CEO & Investor Conference PR Newswire
Dec-30-14 11:47AMPALATIN TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi EDGAR Online
Palatin Technologies, Inc., a biopharmaceutical company, develops peptide therapeutics for the treatment of diseases. The company's clinical development product is Bremelanotide, a peptide melanocortin receptor agonist that has completed Phase 2B clinical trial for the treatment of female sexual dysfunction (FSD). Its drug development programs include Melanocortin receptor-1 agonist peptides for the treatment of inflammatory and dermatologic disease indications; Next Generation Melanocortin receptor-4 peptide agonists, which is in preclinical trials for the treatment of erectile dysfunction; and PL-3994, a natriuretic peptide receptor-A agonist that has completed Phase I clinical trial for the treatment of cardiovascular and pulmonary indications, as well as other melanocortin programs. The company has a license, co-development, and commercialization agreement with Gedeon Richter Plc to commercialize Bremelanotide for FSD in Europe and selected countries; and research collaboration and license agreement with AstraZeneca AB to discover, develop, and commercialize compounds that target melanocortin receptors for the treatment of obesity, diabetes, and related metabolic syndrome. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WILLS STEPHEN TExecutive VP and CFO/COOJul 18Option Exercise0.0055,0000435,068Jan 15 05:07 PM
WILLS STEPHEN TExecutive VP and CFO/COOJul 02Option Exercise0.00100,0000410,488Jan 15 05:05 PM
TickerW [NYSE]
CompanyWayfair Inc.
CountryUSA
IndustryCatalog & Mail Order Houses
Market Cap2.09BEPS (ttm)-1.57
P/E-EPS this Y-22.50%
Forward P/E-EPS next Y32.70%
PEG-EPS past 5Y0.00%
P/S1.88EPS next 5Y28.33%
P/B-EPS Q/Q-238.10%
Dividend-Sales Q/Q87.00%
Insider Own12.10%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float62.52%EarningsMar 04/b
Analyst Recom1.80Target Price35.10
Avg Volume695.25K52W Range16.74 - 39.43
Mar-04-15 12:10PMStory Stocks from Briefing.com Briefing.com
Mar-04-15 11:30AMMcDonalds menu makeover, Wayfair wows Wall St. & Bob Evans board stumbles Yahoo Finance
Mar-04-15 10:24AMWayfair (W) Stock Surging Today on Earnings Beat at TheStreet
Mar-04-15 07:07AMQ4 2014 Wayfair Inc Earnings Release - Before Market Open CCBN
Mar-04-15 07:06AMWAYFAIR INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
Mar-04-15 07:03AM7:03 am Wayfair beats by $0.10, beats on revs; guides Q1 revs above consensus Briefing.com
Mar-04-15 07:00AMWayfair Announces Fourth Quarter and Full Year 2014 Results Business Wire
Mar-02-15 08:00AMBirch Lane Offers Free Shipping on Orders over $49 Business Wire
Mar-02-15 07:00AM5 Hated Earnings Stocks You Should Love: Wayfair, JD.com and More at TheStreet
Feb-11-15 10:51AMHow Do You Handle Tough Feedback at Work? at The Wall Street Journal
Wayfair Inc. engages in the e-commerce business in the United States. The company primarily offers furniture, dcor, lighting, kitchen, bed and bath, outdoor, home improvement, and baby and kids products under the Wayfair.com, Joss & Main, AllModern, DwellStudio, and Birch Lane brands. It also sells its products through retail partners. The company was founded in 2002 and is headquartered in Boston, Massachusetts.
1 2 3 4 5 6 7 8 next